BRIMONIDINE TARTRATE

Somerset Therapeutics, LLC🇺🇸 United States

FDA Page

Effective Date: Oct 9, 2023
Approval ID: cdb8620f-adfa-4433-b285-9c42334f8600
Products: 3 registered
Version: 9

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE tartrate ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 1996

Quick Stats

Total Products3

Labelers2

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.